Cargando…
Antibody glycosylation in COVID-19
Antibody glycosylation has received considerable attention in coronavirus disease 2019 (COVID-19) infections and recently also in vaccination. Antibody glycosylation and in particular immunoglobulin G1 fucosylation levels influence effector functions and are therefore key parameters for assessing th...
Autores principales: | Pongracz, Tamas, Vidarsson, Gestur, Wuhrer, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799414/ https://www.ncbi.nlm.nih.gov/pubmed/35091890 http://dx.doi.org/10.1007/s10719-022-10044-0 |
Ejemplares similares
-
Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
por: Pongracz, Tamas, et al.
Publicado: (2022) -
Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
por: Sonneveld, Myrthe E., et al.
Publicado: (2018) -
MALDI-TOF-MS reveals differential N-linked plasma- and IgG-glycosylation profiles between mothers and their newborns
por: Jansen, Bas C., et al.
Publicado: (2016) -
Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions
por: van Osch, Thijs L. J., et al.
Publicado: (2022) -
Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G
por: Einarsdottir, Helga K., et al.
Publicado: (2012)